Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Familial partial lipodystrophy type 3

Familial partial lipodystrophy type 3 is an autosomal dominant disorder caused by mutations of the PPARG gene.

Systematic

Partial lipodystrophy
Familial partial lipodystrophy type 2
Familial partial lipodystrophy type 3
PPARG
Familial partial lipodystrophy type 4
Familial partial lipodystrophy type 5

References:

1.

Agarwal AK et al. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.

[^]
2.

Hegele RA et al. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.

[^]
3.

Savage DB et al. (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.

[^]
4.

Barroso I et al. () Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

[^]
5.

OMIM.ORG article

Omim 604367 [^]
6.

Orphanet article

Orphanet ID 79083 [^]
Update: May 9, 2019
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues